Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Increasing mass spectrometry throughput using time-encoded sample multiplexing.
Journal: bioRxiv : the preprint server for biology
Published: June 12, 2025
Discovery and Optimization of a Synthetic Class of Nectin-4-Targeted CD137 Agonists for Immuno-oncology.
Journal: Journal of medicinal chemistry
Published: July 12, 2022
BT7480, a novel fully synthetic Bicycle tumor-targeted immune cell agonist™ (Bicycle TICA™) induces tumor localized CD137 agonism.
Journal: Journal for immunotherapy of cancer
Published: October 01, 2021
Anticancer immunity induced by a synthetic tumor-targeted CD137 agonist.
Journal: Journal for immunotherapy of cancer
Published: December 15, 2020
Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy.
Journal: Diabetes care
Published: June 26, 2018
Hepatic FcRn regulates albumin homeostasis and susceptibility to liver injury.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 24, 2017
Comprehensive study of the drug delivery properties of poly(l-lactide)-poly(ethylene glycol) nanoparticles in rats and tumor-bearing mice.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: March 02, 2017
Synthesis and Evaluation of Thiazoloquinolinones with Linkers To Enable Targeting of CD38.
Journal: ACS medicinal chemistry letters
Published: October 14, 2016
Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile.
Journal: Science translational medicine
Published: April 12, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026